Impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients is associated with a blockade in the deactivation of the Notch signaling pathway.
S
S
Xu
H
H
Evans
C
C
Buckle
K
K
De Veirman
J
J
Hu
D
D
Xu
E
E
Menu
A
A
De Becker
I
I
Vande Broek
X
X
Leleu
B V
BV
Camp
P
P
Croucher
K
K
Vanderkerken
I
I
Van Riet
D000818:Animals; D001853:Bone Marrow / Q000378:metabolism / Q000473:pathology*; D002454:Cell Differentiation; D003114:Colony-Forming Units Assay; D005333:Fetus / Q000473:pathology; D006801:Humans; D059630:Mesenchymal Stem Cells / Q000378:metabolism / Q000473:pathology*; D051379:Mice; D008810:Mice, Inbred C57BL; D009101:Multiple Myeloma / Q000378:metabolism / Q000473:pathology*; D010012:Osteogenesis; D051880:Receptors, Notch / Q000037:antagonists & inhibitors* / Q000235:genetics; D015398:Signal Transduction; D014407:Tumor Cells, Cultured
D051880:Receptors, Notch